A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity (Q82459170)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

16 January 2020

main subject

1 reference

Chun-Chi Lu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Yeau-Ching Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jenn-Haung Lai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Tony Szu-Hsien Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Hui-Tsu Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Deh-Ming Chang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

13 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

444-450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Defective B cell tolerance checkpoints in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Lupus: Key Pathogenic Mechanisms and Contributing Factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

B cell receptor signaling in human systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Vaccination and autoimmune disease: what is the evidence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Serum antibody responses after intradermal vaccination against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Vaccine-induced autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Influenza Immunization in Lupus Erythematosus: Safe, Effective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Influenza immunization in systemic lupus eruthematosus. A double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Influenza vaccination of patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Influenzal Vaccine Response in Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Clinical and Antibody Responses After Influenza Immunization in Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Vaccination of the immunosuppressed adult patient with rheumatologic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Vaccinations and Risk of Central Nervous System Demyelinating Diseases in Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Influenza vaccination in systemic lupus erythematosus: safe and protective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.081

10.1016/J.VACCINE.2010.10.081

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21078406%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference